← Leaderboards
John M Dewitt
Pennsylvania State Univ Hershey Med Ctr
$1,065,753
Attributed
$2,131,506
Total exposure
1
Grants
0
Lead (contact PI)
Attributed= this PI's even-split share of every grant they're on (the fair, additive number). Exposure = full size of all those grants.
Funding over time
peak $463.7K · FY2018–22$500K$375K$250K$125K$0
'18
'19
'20
'21
'22
Funding mix
By agency
NIH$2,131,506 · 1
By mechanism
R01$2,131,506 · 1
Top collaborators
- Matthew T. Moyer5 shared
Most similar at Pennsylvania State Univ Hershey Med Ctr
Same institution · by research overlap
- Pankaj Kumar Singh$18,899,559
- Daniel Malamud$17,592,139
- Matthew T. Moyer$1,065,753
- Richard S. Legro$15,817,930
- Joshua P Cysyk$6,315,593
Others in their field
Other Emerging Leaders on “Ablation”
- James Jeffrey Sahn · 4e Therapeutics Inc.$7,064,669
- Kenneth B. Bader · University Of Chicago$6,109,156
- John R Lukens · University Of Virginia$5,842,869
- Juliette Elizabeth McGregor · University Of Rochester$5,567,728
- Jie Shen · Washington University$5,388,462
- Ashley E Webb · Brown University$5,147,077
Research focus
AblationDouble-Blind MethodAdmixtureAdultAbdominal PainAcute PancreatitisAging PopulationAlcohol ConsumptionAspirate SubstanceBaseAdverse EventCaringCessation Of LifeChemotherapeutic AgentChemotherapyClinically SignificantCombination Drug TherapyCostCystCystic LesionDesignDiagnosisCancer EtiologyDyes
Grant awards (5)
CHARM 2: Chemotherapy for ablation and resolution of mucinous pancreatic cysts: a prospective, randomized, double-blind, multi-center clinical trial$409,653
R01 · FY2022 · CA
CHARM 2: Chemotherapy for ablation and resolution of mucinous pancreatic cysts: a prospective, randomized, double-blind, multi-center clinical trial$413,177
R01 · FY2021 · CA
CHARM 2: Chemotherapy for ablation and resolution of mucinous pancreatic cysts: a prospective, randomized, double-blind, multi-center clinical trial$431,536
R01 · FY2020 · CA
CHARM 2: Chemotherapy for ablation and resolution of mucinous pancreatic cysts: a prospective, randomized, double-blind, multi-center clinical trial$413,443
R01 · FY2019 · CA
CHARM 2: Chemotherapy for ablation and resolution of mucinous pancreatic cysts: a prospective, randomized, double-blind, multi-center clinical trial$463,697
R01 · FY2018 · CA